Back to Journals » Breast Cancer: Targets and Therapy » Volume 10

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

Total article views   Abstract views HTML views PDF downloads Totals
4,624 Dovepress* 3,932 418+ 669 4,350
PubMed Central* 0 274 69 274
Totals 3,932 692 738 4,624
*Since 22 March 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
40 1 0 0 7 32

View citations on PubMed Central and Google Scholar